Lumida
/CRBU
⌘K
Caribou Biosciences Inc

Caribou Biosciences Inc

CRBU
$1.27USD-7.30%-0.10 today

MARKET CAP

136.2M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$4
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$9.6M$13.9M$34.5M$10.0M$11.2M
YoY %+44.3%+148.9%-71.0%+11.7%
P / Sales49.8x29.0x11.9x14.4x13.3x
EV / Sales30.4x30.1x12.3x18.8x17.0x
Gross Profit, Adj.$9.6M$13.9M$34.5M$10.0M$11.2M
YoY %+44.3%+148.9%-71.0%+11.7%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit30.4x30.1x12.3x18.8x17.0x
EBITDA, Adj.$-66.0M$-104.8M$-112.5M$-162.7M$-132.5M
YoY %-58.8%-7.4%-44.6%+18.5%
Margin %-687.6%-756.5%-326.4%-1627.9%-1187.8%
EV / EBITDA-4.4x-4.0x-3.8x-1.2x-1.4x
EBIT$-67.0M$-106.4M$-116.1M$-166.6M$-148.3M
YoY %-58.9%-9.1%-43.6%+11.0%
Margin %-697.8%-768.2%-336.6%-1667.2%-1329.4%
EV / EBIT-4.4x-3.9x-3.7x-1.1x-1.3x
Net Income$-66.9M$-99.4M$-102.1M$-148.9M$-148.3M
YoY %-48.6%-2.7%-45.9%+0.4%
Net Margin-697.3%-717.8%-296.1%-1489.7%-1328.8%
EPS (GAAP)-$2.11-$1.64-$1.38-$1.65-$1.59
YoY %+22.3%+15.9%-19.6%+3.6%